The Experts below are selected from a list of 297 Experts worldwide ranked by ideXlab platform
Miyuki Kawado - One of the best experts on this subject based on the ideXlab platform.
-
Medical History of circulatory diseases and colorectal cancer death in the JACC Study.
Journal of epidemiology, 2005Co-Authors: Yoshiyuki Watanabe, Kotaro Ozasa, Yoshinori Ito, Koji Suzuki, Masayo Kojima, Sadao Suzuki, Shinkan Tokudome, Koji Tamakoshi, Hideaki Toyoshima, Miyuki KawadoAbstract:Host factors expressed by individual past Medical History of hypertension, stroke, and myocardial infarction may have a relationship with colorectal cancer. As part of the Japan Collaborative Cohort Study (JACC Study) for the Evaluation of Cancer Risk sponsored by the Ministry of Education, Science, Sports and Culture of Japan (Monbusho), we conducted a follow-up study of 110,792 Japanese inhabitants aged 40-79 years to reveal the relationship of past Medical History of hypertension, stroke, and myocardial infarction at the baseline in 1988-1990 with colorectal cancer death for about 10 years up to the end of 1999. Past Medical History of hypertension associated with an increased risk of female rectal cancer when analyzing all cancer cases with adjustment for age, body mass index, and exercise (hazard ratio [HR]=1.97, 95% confidence interval [CI]; 1.13-3.43). Past Medical History of myocardial infarction was also an increased risk for female rectal cancer (HR=3.05, 95% CI; 1.28-7.28). Females who had a Medical History of stroke had increased risk of rectal cancer without statistical significance. There was a positive association of past Medical History of hypertension and myocardial infarction and an increased risk of rectal cancer in women.
-
Medical History of circulatory diseases and colorectal cancer death in the JACC Study.
Journal of Epidemiology, 2005Co-Authors: Yoshiyuki Watanabe, Kotaro Ozasa, Yoshinori Ito, Koji Suzuki, Masayo Kojima, Sadao Suzuki, Shinkan Tokudome, Koji Tamakoshi, Hideaki Toyoshima, Miyuki KawadoAbstract:BACKGROUND: Host factors expressed by individual past Medical History of hypertension, stroke, and myocardial infarction may have a relationship with colorectal cancer.METHODS: As part of the Japan Collaborative Cohort Study (JACC Study) for the Evaluation of Cancer Risk sponsored by the Ministry of Education, Science, Sports and Culture of Japan (Monbusho), we conducted a follow-up study of 110,792 Japanese inhabitants aged 40-79 years to reveal the relationship of past Medical History of hypertension, stroke, and myocardial infarction at the baseline in 1988-1990 with colorectal cancer death for about 10 years up to the end of 1999.RESULTS: Past Medical History of hypertension associated with an increased risk of female rectal cancer when analyzing all cancer cases with adjustment for age, body mass index, and exercise (hazard ratio [HR] = 1.97, 95% confidence interval [CI]; 1.13-3.43). Past Medical History of myocardial infarction was also an increased risk for female rectal cancer (HR = 3.05, 95% CI; 1.28-7.28). Females who had a Medical History of stroke had increased risk of rectal cancer without statistical significance.CONCLUSION: There was a positive association of past Medical History of hypertension and myocardial infarction and an increased risk of rectal cancer in women.J Epidemiol 2005;15:S168-S172.
Thomas Strowitzki - One of the best experts on this subject based on the ideXlab platform.
-
Medical History screening for thrombophilic risk: is this adequate?
Fertility and sterility, 2011Co-Authors: Waltraud Eggert-kruse, Andrea Ziegler, Sandra Horlbeck, Thomas StrowitzkiAbstract:Objective To evaluate the reliability of Medical History taken before hormonal medication administration to identify women with an increased risk for thromboembolic events detected by laboratory screening. Design Prospective study. Setting Outpatient endocrine clinic of a university-based hospital. Patient(s) Four hundred forty-three consecutive women (median age 49 years) who presented with endocrine disorders. Intervention(s) None. Main Outcome Measure(s) Parallel screening, on first visit, with a complete Medical History, and same-day laboratory screening for thromboembolic risk. Laboratory examination in a two-step procedure with a standard assay and confirmation by genotyping on the second visit. Result(s) A total of 13.8% (61/443) patients with an abnormal activated protein C (APC) resistance test were identified. Second blood samples revealed a prevalence of factor V (Leiden) heterozygosity in 10.9% (homozygosity in 0.2%). There was a significantly higher prevalence of thrombotic events in a first degree relative of patients with APC resistance (in 18.3%) compared with women with a normal test outcome (in 7.8%). However, Medical History (personal and family History) was negative concerning hints for thromboembolic events in more than 80% of patients with a laboratory risk profile for thromboembolic morbidity. No association of APC and factor V testing with the patients' gynecological/obstetric History (e.g., live birth rate, miscarriages) was observed. Conclusion(s) Medical History alone may be inadequate to identify all patients at risk for thromboembolic complications with hormonal treatment.
Albert-lászló Barabási - One of the best experts on this subject based on the ideXlab platform.
-
Predicting individual disease risk based on Medical History
Proceeding of the 17th ACM conference on Information and knowledge mining - CIKM '08, 2008Co-Authors: Darcy A. Davis, Nicholas Blumm, Nicholas A Christakis, Nitesh V. Chawla, Albert-lászló BarabásiAbstract:The monumental cost of health care, especially for chronic disease treatment, is quickly becoming unmanageable. This crisis has motivated the drive towards preventative medicine, where the primary concern is recognizing disease risk and taking action at the earliest signs. However, universal test- ing is neither time nor cost efficient. We propose CARE, a Collaborative Assessment and Recommendation Engine, which relies only on a patient’s Medical History using ICD- 9-CM codes in order to predict future diseases risks. CARE uses collaborative filtering to predict each patient’s greatest disease risks based on their own Medical History and that of similar patients. We also describe an Iterative version, ICARE, which incorporates ensemble concepts for improved performance. These novel systems require no specialized in- formation and provide predictions for Medical conditions of all kinds in a single run. We present experimental results on a Medicare dataset, demonstrating that CARE and ICARE perform well at capturing future disease risks.
Yoshiyuki Watanabe - One of the best experts on this subject based on the ideXlab platform.
-
Medical History of circulatory diseases and colorectal cancer death in the JACC Study.
Journal of epidemiology, 2005Co-Authors: Yoshiyuki Watanabe, Kotaro Ozasa, Yoshinori Ito, Koji Suzuki, Masayo Kojima, Sadao Suzuki, Shinkan Tokudome, Koji Tamakoshi, Hideaki Toyoshima, Miyuki KawadoAbstract:Host factors expressed by individual past Medical History of hypertension, stroke, and myocardial infarction may have a relationship with colorectal cancer. As part of the Japan Collaborative Cohort Study (JACC Study) for the Evaluation of Cancer Risk sponsored by the Ministry of Education, Science, Sports and Culture of Japan (Monbusho), we conducted a follow-up study of 110,792 Japanese inhabitants aged 40-79 years to reveal the relationship of past Medical History of hypertension, stroke, and myocardial infarction at the baseline in 1988-1990 with colorectal cancer death for about 10 years up to the end of 1999. Past Medical History of hypertension associated with an increased risk of female rectal cancer when analyzing all cancer cases with adjustment for age, body mass index, and exercise (hazard ratio [HR]=1.97, 95% confidence interval [CI]; 1.13-3.43). Past Medical History of myocardial infarction was also an increased risk for female rectal cancer (HR=3.05, 95% CI; 1.28-7.28). Females who had a Medical History of stroke had increased risk of rectal cancer without statistical significance. There was a positive association of past Medical History of hypertension and myocardial infarction and an increased risk of rectal cancer in women.
-
Medical History of circulatory diseases and colorectal cancer death in the JACC Study.
Journal of Epidemiology, 2005Co-Authors: Yoshiyuki Watanabe, Kotaro Ozasa, Yoshinori Ito, Koji Suzuki, Masayo Kojima, Sadao Suzuki, Shinkan Tokudome, Koji Tamakoshi, Hideaki Toyoshima, Miyuki KawadoAbstract:BACKGROUND: Host factors expressed by individual past Medical History of hypertension, stroke, and myocardial infarction may have a relationship with colorectal cancer.METHODS: As part of the Japan Collaborative Cohort Study (JACC Study) for the Evaluation of Cancer Risk sponsored by the Ministry of Education, Science, Sports and Culture of Japan (Monbusho), we conducted a follow-up study of 110,792 Japanese inhabitants aged 40-79 years to reveal the relationship of past Medical History of hypertension, stroke, and myocardial infarction at the baseline in 1988-1990 with colorectal cancer death for about 10 years up to the end of 1999.RESULTS: Past Medical History of hypertension associated with an increased risk of female rectal cancer when analyzing all cancer cases with adjustment for age, body mass index, and exercise (hazard ratio [HR] = 1.97, 95% confidence interval [CI]; 1.13-3.43). Past Medical History of myocardial infarction was also an increased risk for female rectal cancer (HR = 3.05, 95% CI; 1.28-7.28). Females who had a Medical History of stroke had increased risk of rectal cancer without statistical significance.CONCLUSION: There was a positive association of past Medical History of hypertension and myocardial infarction and an increased risk of rectal cancer in women.J Epidemiol 2005;15:S168-S172.
Waltraud Eggert-kruse - One of the best experts on this subject based on the ideXlab platform.
-
Medical History screening for thrombophilic risk: is this adequate?
Fertility and sterility, 2011Co-Authors: Waltraud Eggert-kruse, Andrea Ziegler, Sandra Horlbeck, Thomas StrowitzkiAbstract:Objective To evaluate the reliability of Medical History taken before hormonal medication administration to identify women with an increased risk for thromboembolic events detected by laboratory screening. Design Prospective study. Setting Outpatient endocrine clinic of a university-based hospital. Patient(s) Four hundred forty-three consecutive women (median age 49 years) who presented with endocrine disorders. Intervention(s) None. Main Outcome Measure(s) Parallel screening, on first visit, with a complete Medical History, and same-day laboratory screening for thromboembolic risk. Laboratory examination in a two-step procedure with a standard assay and confirmation by genotyping on the second visit. Result(s) A total of 13.8% (61/443) patients with an abnormal activated protein C (APC) resistance test were identified. Second blood samples revealed a prevalence of factor V (Leiden) heterozygosity in 10.9% (homozygosity in 0.2%). There was a significantly higher prevalence of thrombotic events in a first degree relative of patients with APC resistance (in 18.3%) compared with women with a normal test outcome (in 7.8%). However, Medical History (personal and family History) was negative concerning hints for thromboembolic events in more than 80% of patients with a laboratory risk profile for thromboembolic morbidity. No association of APC and factor V testing with the patients' gynecological/obstetric History (e.g., live birth rate, miscarriages) was observed. Conclusion(s) Medical History alone may be inadequate to identify all patients at risk for thromboembolic complications with hormonal treatment.
